On 24 April 2020, advocates sent an open letter to the Diagnostics Supply Consortium calling for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to molecular diagnostic testing for COVID-19, as well as to address the decades-long global health crisis that unaffordability and lack of access to testing for TB, HIV, HCV and other diseases has presented in low- and middle-income countries.

Read/Download 4/24/20 Letter to Diagnostics Supply Consortium